nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—Calculus of kidney—Formoterol—chronic obstructive pulmonary disease	0.0498	0.0498	CcSEcCtD
Phenazopyridine—Calculus of kidney—Arformoterol—chronic obstructive pulmonary disease	0.0498	0.0498	CcSEcCtD
Phenazopyridine—Nephrolithiasis—Formoterol—chronic obstructive pulmonary disease	0.0406	0.0406	CcSEcCtD
Phenazopyridine—Nephrolithiasis—Arformoterol—chronic obstructive pulmonary disease	0.0406	0.0406	CcSEcCtD
Phenazopyridine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.0202	0.0202	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.0198	0.0198	CcSEcCtD
Phenazopyridine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.0196	0.0196	CcSEcCtD
Phenazopyridine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.0174	0.0174	CcSEcCtD
Phenazopyridine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0169	0.0169	CcSEcCtD
Phenazopyridine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.0168	0.0168	CcSEcCtD
Phenazopyridine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.016	0.016	CcSEcCtD
Phenazopyridine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.0158	0.0158	CcSEcCtD
Phenazopyridine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.0158	0.0158	CcSEcCtD
Phenazopyridine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0157	0.0157	CcSEcCtD
Phenazopyridine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0146	0.0146	CcSEcCtD
Phenazopyridine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0145	0.0145	CcSEcCtD
Phenazopyridine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0144	0.0144	CcSEcCtD
Phenazopyridine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0144	0.0144	CcSEcCtD
Phenazopyridine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0136	0.0136	CcSEcCtD
Phenazopyridine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.0135	0.0135	CcSEcCtD
Phenazopyridine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.0135	0.0135	CcSEcCtD
Phenazopyridine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.0127	0.0127	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0124	0.0124	CcSEcCtD
Phenazopyridine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0113	0.0113	CcSEcCtD
Phenazopyridine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0108	0.0108	CcSEcCtD
Phenazopyridine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0106	0.0106	CcSEcCtD
Phenazopyridine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0105	0.0105	CcSEcCtD
Phenazopyridine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Phenazopyridine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Phenazopyridine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.01	0.01	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.01	0.01	CcSEcCtD
Phenazopyridine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.01	0.01	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00984	0.00984	CcSEcCtD
Phenazopyridine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00972	0.00972	CcSEcCtD
Phenazopyridine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00967	0.00967	CcSEcCtD
Phenazopyridine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00964	0.00964	CcSEcCtD
Phenazopyridine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00963	0.00963	CcSEcCtD
Phenazopyridine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00958	0.00958	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00948	0.00948	CcSEcCtD
Phenazopyridine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00917	0.00917	CcSEcCtD
Phenazopyridine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00909	0.00909	CcSEcCtD
Phenazopyridine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00908	0.00908	CcSEcCtD
Phenazopyridine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00908	0.00908	CcSEcCtD
Phenazopyridine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00903	0.00903	CcSEcCtD
Phenazopyridine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00857	0.00857	CcSEcCtD
Phenazopyridine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00857	0.00857	CcSEcCtD
Phenazopyridine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00856	0.00856	CcSEcCtD
Phenazopyridine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00855	0.00855	CcSEcCtD
Phenazopyridine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0084	0.0084	CcSEcCtD
Phenazopyridine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00823	0.00823	CcSEcCtD
Phenazopyridine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00823	0.00823	CcSEcCtD
Phenazopyridine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00809	0.00809	CcSEcCtD
Phenazopyridine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00806	0.00806	CcSEcCtD
Phenazopyridine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00796	0.00796	CcSEcCtD
Phenazopyridine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00796	0.00796	CcSEcCtD
Phenazopyridine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0078	0.0078	CcSEcCtD
Phenazopyridine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00777	0.00777	CcSEcCtD
Phenazopyridine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00752	0.00752	CcSEcCtD
Phenazopyridine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0074	0.0074	CcSEcCtD
Phenazopyridine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0074	0.0074	CcSEcCtD
Phenazopyridine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00734	0.00734	CcSEcCtD
Phenazopyridine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00734	0.00734	CcSEcCtD
Phenazopyridine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00733	0.00733	CcSEcCtD
Phenazopyridine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00733	0.00733	CcSEcCtD
Phenazopyridine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00729	0.00729	CcSEcCtD
Phenazopyridine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00729	0.00729	CcSEcCtD
Phenazopyridine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00725	0.00725	CcSEcCtD
Phenazopyridine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00719	0.00719	CcSEcCtD
Phenazopyridine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00718	0.00718	CcSEcCtD
Phenazopyridine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00714	0.00714	CcSEcCtD
Phenazopyridine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00698	0.00698	CcSEcCtD
Phenazopyridine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00693	0.00693	CcSEcCtD
Phenazopyridine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00692	0.00692	CcSEcCtD
Phenazopyridine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00691	0.00691	CcSEcCtD
Phenazopyridine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00691	0.00691	CcSEcCtD
Phenazopyridine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00688	0.00688	CcSEcCtD
Phenazopyridine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00677	0.00677	CcSEcCtD
Phenazopyridine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00653	0.00653	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Phenazopyridine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00403	0.00403	CcSEcCtD
Phenazopyridine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Phenazopyridine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00395	0.00395	CcSEcCtD
Phenazopyridine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Phenazopyridine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00324	0.00324	CcSEcCtD
Phenazopyridine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00313	0.00313	CcSEcCtD
Phenazopyridine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Phenazopyridine—Rash—Prednisone—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Phenazopyridine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00287	0.00287	CcSEcCtD
Phenazopyridine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
